| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e139d83c3615643498693c9d3dbba145
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_70842a16c24fe9027a16e5f1b995adf4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cb8f3eba86915d967beefc175437273a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a963f578a06e1ff9cf85626cda236b5d |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-71 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57434
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate |
2000-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7784cc58569bec5e522cb035cdb9b778
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_76fbad2a98c8fbfc7c9bfa4da33c1998
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a939515d6e93959c6c7a741bc6f2fd3 |
| publicationDate |
2000-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-0077258-A1 |
| titleOfInvention |
Markers for prostate cancer |
| abstract |
This invention provides a method for determining the aggressiveness of a prostate carcinoma comprising: (a) obtaining a sample of the prostate carcinoma; and (b) detecting the presence of p27 protein in the prostate carcinoma, the absence of p27 indicating that the prostate carcinoma is aggressive. This invention also provides a method for diagnosing a benign prostate hyperplasia comprising: (a) obtaining an appropriate sample of the hyperplasia; and (b) detecting the presence of the p27 RNA, a decrease of the p27 RNA indicating that the hyperplasia is benign. This invention provides various uses of p27 in prostate cancer. Finally, this invention also provides different marker for prostate cancer. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10604812-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9994912-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004113571-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004113571-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8722340-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3530751-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006031210-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7834163-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6972170-B1 |
| priorityDate |
1999-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |